3,393
Views
33
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy

Pages 287-293 | Received 11 Oct 2018, Accepted 31 Oct 2018, Published online: 04 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yunyi Gao, Dawei Chen, Yan Li, Huijiao Chen & Xingwu Ran. (2021) Extremity Gangrene Caused by HBV-Related Cryoglobulinemia Vasculitis in a Patient with Diabetes – A Case Report. Journal of Inflammation Research 14, pages 1661-1666.
Read now
Tomoyuki Mukai, Shinichiro Kubo, Yoshitaka Morita, Mari Yamamoto & Masahiko Ikeda. (2020) Aortitis which developed after the administration of granulocyte-colony stimulating factor. Modern Rheumatology Case Reports 4:1, pages 74-78.
Read now

Articles from other publishers (31)

Takahiko Sugihara, Haruhito A Uchida, Hajime Yoshifuji, Yasuhiro Maejima, Taio Naniwa, Yasuhiro Katsumata, Takahiro Okazaki, Jun Ishizaki, Yohko Murakawa, Noriyoshi Ogawa, Hiroaki Dobashi, Tetsuya Horita, Yoshiya Tanaka, Shunsuke Furuta, Tsutomu Takeuchi, Yoshinori Komagata, Yoshikazu Nakaoka & Masayoshi Harigai. (2023) Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis. Modern Rheumatology 33:6, pages 1145-1153.
Crossref
Masayoshi Harigai, Takako Miyamae, Hideyuki Hashimoto, Amika Yoshida, Katsuhisa Yamashita & Yoshikazu Nakaoka. (2023) A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study. Modern Rheumatology 33:5, pages 998-1006.
Crossref
Toshio Kawamoto, Michihiro Ogasawara, Go Murayama, Yuko Matsuki-Muramoto, Eri Hayashi, Mariko Harada, Makio Kusaoi, Masakazu Matsushita, Ken Yamaji & Naoto Tamura. (2023) Transitions in vascular ultrasonography findings of temporal arteritis in a GCA case with progressive temporal headache and visual impairment. Modern Rheumatology Case Reports.
Crossref
Masayoshi Harigai, Takako Miyamae, Hideyuki Hashimoto, Kosei Umetsu, Katsuhisa Yamashita & Yoshikazu Nakaoka. (2023) A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan. Modern Rheumatology.
Crossref
Young Min Cho, Lara El Khoury, Jonathan Paramo, Diane Michelle Horowitz, Jian Yi Li & Nina Kello. (2023) Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report. BMC Musculoskeletal Disorders 24:1.
Crossref
Yusuke Manabe, Tomohiko Ishibashi, Ryotaro Asano, Shuichi Tonomura, Yuichi Maeda, Daisuke Motooka, Jin Ueda, Masahiro Yanagawa, Yuko Edamoto-Taira, Tomomi Chikaishi-Kirino, Takeshi Masaki, Tadakatsu Inagaki, Shota Nakamura, Yoshinori Katada, Makoto Okazawa, Masashi Narazaki, Takeshi Ogo, Atsushi Kumanogoh & Yoshikazu Nakaoka. (2023) Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis. Arthritis Research & Therapy 25:1.
Crossref
Cong-Qiu Chu. (2023) Animal models for large vessel vasculitis – The unmet need. Rheumatology and Immunology Research 4:1, pages 4-10.
Crossref
Regina Miecznikoski Phillips. (2023) Vasculitis: Complex, Challenging, and Dangerous. Journal of Radiology Nursing 42:1, pages 90-94.
Crossref
Ruifang Liu, Fangxing Xu, Yujie Zhou, Dongmei Shi & Tongku Liu. (2023) Clinical and vascular lesion characteristics of the patients with takayasu arteritis manifested firstly as acute myocardial infarction at onset. Heliyon 9:2, pages e13099.
Crossref
Debashish Danda, Prathyusha Manikuppam, Xinping Tian & Masayoshi Harigai. (2022) Advances in Takayasu arteritis: An Asia Pacific perspective. Frontiers in Medicine 9.
Crossref
Yukiko Seto, Nobuyoshi Kittaka, Azusa Taniguchi, Haruka Kanaoka, Satomi Nakajima, Yuri Oyama, Hiroki Kusama, Noriyuki Watanabe, Saki Matsui, Minako Nishio, Fumie Fujisawa, Koji Takano, Hideyuki Arita & Takahiro Nakayama. (2022) Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature. Surgical Case Reports 8:1.
Crossref
Nooran Badeeb & Rustum Karanjia. (2022) Efficacy and Safety of Tocilizumab in the Treatment of Ocular Manifestations in Giant Cell Arteritis. Advances in Ophthalmology and Optometry 7:1, pages 295-309.
Crossref
L. S. Ovcharenko, A. O. Vertegel, I. I. Redko, T. G. Andrienko, I. V. Samohin, O. V. Kryazhev & O. M. Chakmazova. (2022) SERUM LEVEL OF SOME CYTOKINES IN CHILDREN 6-10 YEARS OLD WITH HIGH FREQUENCY OF ACUTE RESPIRATORY INFECTIONS. Modern medical technology:2(53), pages 15-18.
Crossref
Yoshikazu Nakaoka, Masahiro Yanagawa, Akinori Hata, Katsuhisa Yamashita, Norihiro Okada, Shinji Yamakido, Hiromitsu Hayashi & David Jayne. (2022) Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial . Rheumatology 61:6, pages 2360-2368.
Crossref
Ujalashah Dhanani, Michael Y. Zhao, Chaow Charoenkijkajorn, Mohammad Pakravan, Peter W. Mortensen & Andrew G. Lee. (2022) Large-Vessel Vasculitis in Ophthalmology: Giant Cell Arteritis and Takayasu Arteritis. Asia-Pacific Journal of Ophthalmology 11:2, pages 177-183.
Crossref
Francesca Regola, Martina Uzzo, Paola Toniati, Barbara Trezzi, Renato Alberto Sinico & Franco Franceschini. (2022) Novel Therapies in Takayasu Arteritis. Frontiers in Medicine 8.
Crossref
Hua Liao, Juan Du, Taotao Li & Lili Pan. (2022) Tocilizumab for faster and safer remission of Takayasu’s arteritis. Therapeutic Advances in Chronic Disease 13, pages 204062232211317.
Crossref
Masahiro Kondo, Yohko Murakawa, Sakae Kaneko, Teruaki Iwahashi, Manabu Honda & Mayuko Moriyama. (2021) Takayasu arteritis developing during the course of palmoplantar pustulosis. International Journal of Rheumatic Diseases 24:7, pages 970-972.
Crossref
Kevin W Loudon, Jasvir Parmar, David R W Jayne & Rachel B. Jones. (2021) Aggressive vasculitis after lung transplantation for cystic fibrosis. Rheumatology 60:Supplement_3, pages iii47-iii49.
Crossref
Christopher Kirkegaard Torp, Mads Brüner, Kresten Krarup Keller, Elisabeth Brouwer, Ellen-Margrethe Hauge, Dennis McGonagle & Tue Wenzel Kragstrup. (2021) Vasculitis therapy refines vasculitis mechanistic classification. Autoimmunity Reviews 20:6, pages 102829.
Crossref
Shuyue Wang, Fei Guo, Xiaochen Sun, Xiao Song, Yaohui Yuan, Chao Zhang, Guitao Lin & Huagang Sheng. (2021) Study on the Potential Mechanism of Fructus Tribuli in the Treatment of Hypertensive Vascular Remodeling Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-17.
Crossref
Hajime Yoshifuji & Chikashi Terao. (2020) Roles of cytotoxic lymphocytes and MIC/LILR families in pathophysiology of Takayasu arteritis. Inflammation and Regeneration 40:1.
Crossref
Ying Sun, Xiufang Kong, Xiaomeng Cui, Xiaomin Dai, Lili Ma, Huiyong Chen, Rongyi Chen, Peng Lv, Jiang Lin, Qingrong Huang, Xuejuan Jin & Lindi Jiang. (2020) The value of interleukin-6 in predicting disease relapse for Takayasu arteritis during 2-year follow-up. Clinical Rheumatology 39:11, pages 3417-3425.
Crossref
Ryu Watanabe, Gerald J. Berry, David H. Liang, Jörg J. Goronzy & Cornelia M. Weyand. (2020) Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences. Current Rheumatology Reports 22:10.
Crossref
Ryu Watanabe, Gerald J. Berry, David H. Liang, Jörg J. Goronzy & Cornelia M. Weyand. (2020) Cellular Signaling Pathways in Medium and Large Vessel Vasculitis. Frontiers in Immunology 11.
Crossref
Shuntaro Saito, Ayumi Okuyama, Yusuke Okada, Akiko Shibata, Ryota Sakai, Takahiko Kurasawa, Tsuneo Kondo, Hirofumi Takei & Koichi Amano. (2020) Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study. Rheumatology 59:7, pages 1617-1621.
Crossref
Serena Colafrancesco, Rossana Scrivo, Cristiana Barbati, Fabrizio Conti & Roberta Priori. (2020) Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients. Frontiers in Immunology 11.
Crossref
Alfredo Sadun & Lynn Gordon. (2020) Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?. Journal of Neuro-Ophthalmology 40:1, pages 117-121.
Crossref
Jifeng Zhang, Lei Zhao, Jing Wang, Zhihua Cheng, Mengyao Sun, Jiayi Zhao, Bin Liu, Xiyu Liu, Zhenke Wen & Zhibo Li. (2019) Targeting Mechanistic Target of Rapamycin Complex 1 Restricts Proinflammatory T Cell Differentiation and Ameliorates Takayasu Arteritis. Arthritis & Rheumatology 72:2, pages 303-315.
Crossref
Tomoyuki Asano, Shuzo Sato, Jumpei Temmoku, Yuya Fujita, Makiko Yashiro Furuya, Naoki Matsuoka, Hiroko Kobayashi, Eiji SuzukiHiroshi Watanabe & Kiyoshi Migita. (2020) Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis. Medicine 99:4, pages e18890.
Crossref
Junichi Tsuchiya, Ukihide Tateishi, Hajime Yoshifuji, Hideo Onizawa, Yukio Sato, Masatoshi Itoh, Takeshi Sasaki, Tadashi Watabe, Tetsuya Higuchi, Shinro Matsuo, Chao Cheng, Zhang Jingping, Jun Hashimoto, Yuri Yamada, Toshiki Kazama, Takakiyo Nomura, Yutaka Imai, Xuena Li & Kazuo Kubota. 2020. PET/CT for Inflammatory Diseases. PET/CT for Inflammatory Diseases 115 146 .